<DOC>
	<DOCNO>NCT01788007</DOCNO>
	<brief_summary>The objective study compare relative efficacy safety test formulation Imiquimod 3.75 % Topical Cream market formulation Zyclara® ( imiquimod ) 3.75 % Topical Cream treatment actinic keratosis . Both test reference formulation also compare placebo cream test superiority .</brief_summary>
	<brief_title>Clinical Study Evaluate Bioequivalence Two Imiquimod Cream 3.75 % Formulations Patients With Actinic Keratosis .</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>Signed informed consent form . Immunocompetent male nonpregnant , nonlactating female least 18 year age . Diagnosis actinic keratosis least 5 20 clinically typical , visible palpable actinic keratosis lesion , least 4 mm diameter , area exceeds 25 cm2 either face ( exclude ear ) balding scalp ( . ) Women either must 1 year postmenopausal , surgically sterile , childbearing potential , must : ) use systemic birth control , intrauterine device , Norplant least 28 day prior start treatment period , use barrier method consistently , least 14 day study cream administration ; b ) normal menstrual cycle month prior start treatment ; c ) negative urine pregnancy test result upon entry study ; ) agree use medically accept form birth control throughout study period . Free systemic dermatologic disorder , opinion Investigator , interfere study result increase risk adverse event . Any skin type race , provide skin pigmentation allow discernment erythema . Willingness capability cooperate extent degree require protocol . Presence atopic dermatitis , basal cell carcinoma , squamous cell carcinoma , eczema , psoriasis , rosacea , sunburn possible confound skin condition face bald scalp . Use within six month prior baseline face bald scalp chemical peel , dermabrasion , laser abrasion , psoralen plus ultraviolet A therapy , ultra violet B therapy . Use within one month prior baseline face bald scalp cryodestruction chemodestruction , curettage , photodynamic therapy , surgical excision , topical 5fluorouracil , topical corticosteroid , topical diclofenac , topical imiquimod , topical retinoids treatment actinic keratosis include glycolic acid overthecounter product contain retinol , alpha beta hydroxy acid . Use within one month prior baseline immunomodulators immunosuppressive therapy , interferon , oral corticosteroid cytotoxic drug . Known allergy imiquimod excipients test reference cream . Receiving 5fluorouracil systemic cancer chemotherapy within 6 month prior study entry . Any condition , medical , psychological , social , , Investigator 's opinion , would interfere participation study . Women pregnant planning pregnancy lactate study . Participation investigational drug study within 30 day enrollment previous participation study . Employees family member employee research center Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Actinic Keratosis</keyword>
	<keyword>Imiquimod Topical Cream 3.75 %</keyword>
	<keyword>Zyclara® ( imiquimod ) Topical Cream 3.75 %</keyword>
</DOC>